Joel Greenblatt's LLY Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 11,308 shares of Eli Lilly and Company (LLY) worth $12.15 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in LLY, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2017, adding 410,286 shares. Largest reduction occurred in Q2 2017, reducing 439,592 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +3,292 | Add 41.07% | 11,308 | $1074.68 |
| Q3 2025 | +830 | Add 11.55% | 8,016 | $763.00 |
| Q2 2025 | -361 | Reduce 4.78% | 7,186 | $779.53 |
| Q1 2025 | +1,768 | Add 30.59% | 7,547 | $825.91 |
| Q4 2024 | -2,736 | Reduce 32.13% | 5,779 | $772.00 |
| Q3 2024 | -3,434 | Reduce 28.74% | 8,515 | $885.94 |
| Q2 2024 | +2,065 | Add 20.89% | 11,949 | $905.38 |
| Q1 2024 | +620 | Add 6.69% | 9,884 | $777.96 |
| Q4 2023 | +1,878 | Add 25.43% | 9,264 | $582.92 |
| Q3 2023 | +3,891 | Add 111.33% | 7,386 | $537.13 |
| Q2 2023 | -224 | Reduce 6.02% | 3,495 | $468.98 |
| Q1 2023 | +42 | Add 1.14% | 3,719 | $343.42 |
| Q4 2022 | +58 | Add 1.60% | 3,677 | $365.84 |
| Q3 2022 | +198 | Add 5.79% | 3,619 | $323.29 |
| Q2 2022 | +81 | Add 2.43% | 3,421 | $324.17 |
| Q1 2022 | +814 | Add 32.22% | 3,340 | $286.23 |
| Q4 2021 | -31,213 | Reduce 92.51% | 2,526 | $276.33 |
| Q3 2021 | +31,854 | Add 1689.87% | 33,739 | $231.04 |
| Q2 2021 | -1,667 | Reduce 46.93% | 1,885 | $229.71 |
| Q1 2021 | +3,552 | New Buy | 3,552 | $186.94 |
| Q4 2019 | -105,655 | Sold Out | 0 | $0.00 |
| Q3 2019 | -397,920 | Reduce 79.02% | 105,655 | $111.83 |
| Q2 2019 | +257,782 | Add 104.88% | 503,575 | $110.79 |
| Q1 2019 | -66,667 | Reduce 21.34% | 245,793 | $129.76 |
| Q4 2018 | +242,632 | Add 347.47% | 312,460 | $115.72 |
| Q3 2018 | +69,828 | New Buy | 69,828 | $107.31 |
| Q2 2018 | -90,625 | Sold Out | 0 | $0.00 |
| Q1 2018 | -165,912 | Reduce 64.67% | 90,625 | $77.37 |
| Q4 2017 | +256,537 | New Buy | 256,537 | $84.46 |
| Q3 2017 | -8,999 | Sold Out | 0 | $0.00 |
| Q2 2017 | -439,592 | Reduce 97.99% | 8,999 | $82.34 |
| Q1 2017 | +410,286 | Add 1071.10% | 448,591 | $84.11 |
| Q4 2016 | +38,305 | New Buy | 38,305 | $73.54 |
| Q1 2015 | -5,634 | Sold Out | 0 | $0.00 |
| Q4 2014 | +6 | Add 0.11% | 5,634 | $69.05 |
| Q3 2014 | -2,121 | Reduce 27.37% | 5,628 | $64.85 |
| Q2 2014 | -1,267 | Reduce 14.05% | 7,749 | $62.20 |
| Q1 2014 | -132,105 | Reduce 93.61% | 9,016 | $58.90 |
| Q4 2013 | +94,360 | Add 201.79% | 141,121 | $51.00 |
| Q3 2013 | +7,350 | Add 18.65% | 46,761 | $50.32 |
| Q2 2013 | +39,411 | Add 0.00% | 39,411 | $49.12 |
Joel Greenblatt's Eli Lilly and Company Investment FAQs
Joel Greenblatt first purchased Eli Lilly and Company (LLY) in Q2 2013, acquiring 39,411 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Eli Lilly and Company (LLY) for 41 quarters since Q2 2013.
Joel Greenblatt's largest addition to Eli Lilly and Company (LLY) was in Q1 2017, adding 448,591 shares worth $37.73 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 11,308 shares of Eli Lilly and Company (LLY), valued at approximately $12.15 M.
As of the Q4 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Eli Lilly and Company (LLY) was 503,575 shares, as reported at the end of Q2 2019.